Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
Psychotropics (antipsychotics, mood stabilizers, antidepressants, anxiolytics, etc.) are commonly prescribed to treat Huntington’s disease (HD). In HD preclinical models, while no psychotropic has convincingly affected huntingtin gene, HD modifying gene, or huntingtin protein expression, psychotropi...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/11/22558 |